Renal Tumors in Young Adults: A Systematic Review and Meta-Analysis of Epidemiology, Clinical Features, Histopathology, and Outcomes Over Two Decades

Read full text Summarise with VIRAT
Authors: John Paul Tadifa, Rudolfo De Guzman, Kenneth George Garcia
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Renal tumors in young adults are uncommon and less well characterized compared to those in older populations. This systematic review aimed to determine the epidemiology, clinicopathological features, and outcomes of renal tumors in individuals aged 18–45 years. Methods: Original peer-reviewed cohort studies, randomized controlled trials, and systematic reviews published between 2000 and 2024 were included. Databases searched included PubMed, Scopus, and Web of Science, with the last search conducted in February 2025. Risk of bias was assessed using the Newcastle-Ottawa Scale. A total of 19 studies met the inclusion criteria. Meta-analyses were performed using R (v4.3.1) with a random-effects model. Results: The pooled proportion of incidental tumor diagnoses was 41% (95% confidence interval (CI): 12–77%), while symptomatic tumors accounted for 42% (95% CI: 23–64%). Clear cell renal cell carcinoma (RCC) was the most prevalent histologic subtype (54%), followed by papillary (12%) and chromophobe (7%). The pooled mean tumor size was 6.84 cm. Recurrence and mortality rates were 4% and 8%, respectively. Most studies reported 5-year cancer-specific survival exceeding 90% for localized RCC. Nephron-sparing surgery was performed in more than half of the patients, supporting its safety and effectiveness in early-stage disease. Conclusions: Heterogeneity in outcome reporting, small sample sizes in rare subtypes, and possible publication bias were noted. The review supports the importance of early detection, individualized management, and molecular profiling in aggressive subtypes such as Xp11.2 translocation RCC.

Fields of Study & Subjects

Renal cell carcinoma treatment Adrenal and Paraganglionic Tumors Renal and related cancers

Publication details

Journal / source
World Journal of Nephrology and Urology
Volume
15
Issue
2
Pages
42–54
Publication date
28 March 2026
Language
EN